1999
Expression and localization of thymidine phosphorylase/platelet‐derived endothelial cell growth factor in skin and cutaneous tumors
Asgari M, Haggerty J, McNiff J, Milstone L, Schwartz P. Expression and localization of thymidine phosphorylase/platelet‐derived endothelial cell growth factor in skin and cutaneous tumors. Journal Of Cutaneous Pathology 1999, 26: 287-294. PMID: 10472757, DOI: 10.1111/j.1600-0560.1999.tb01846.x.Peer-Reviewed Original ResearchConceptsPlatelet-derived endothelial cell growth factorThymidine phosphorylase/platelet-derived endothelial cell growth factorPD-ECGF expressionEndothelial cell growth factorCutaneous tumorsPD-ECGFCell carcinomaCell growth factorGrowth factorSquamous cell carcinomaMerkel cell carcinomaBasal cell carcinomaVariety of tumorsCell of originNuclei of keratinocytesFollicular infundibulumTumor degreeDifferentiation of keratinocytesEccrine poromaImmunohistochemical analysisPositive stainingIntradermal nevusNormal skinTumorsIntense staining
1995
Generalized Linear Porokeratosis Treated With Etretinate
Goldman G, Milstone L. Generalized Linear Porokeratosis Treated With Etretinate. JAMA Dermatology 1995, 131: 496-497. DOI: 10.1001/archderm.1995.01690160126029.Peer-Reviewed Case Reports and Technical NotesConceptsLinear porokeratosisLesions of porokeratosisSquamous cell carcinomaTopical vitamin AYears of ageBowen's diseaseHistologic confirmationTherapeutic challengeVerrucous plaquesCell carcinomaVerrucous lesionsTreatment recommendationsD ointmentVitamin AOnly treatmentPorokeratosisLesionsAnterior partWhite menExtensive casesDiseaseBirthRecreational activitiesEtretinateCarcinoma